Diisopropyl Cyanomethylphosphonate, en es it fr

Diisopropyl Cyanomethylphosphonate, Brand names, Diisopropyl Cyanomethylphosphonate, Analogs

Diisopropyl Cyanomethylphosphonate, Brand Names Mixture

  • No information avaliable

Diisopropyl Cyanomethylphosphonate, Chemical_Formula

C6H14FO3P

Diisopropyl Cyanomethylphosphonate, RX_link

No information avaliable

Diisopropyl Cyanomethylphosphonate, fda sheet

Diisopropyl Cyanomethylphosphonate, msds (material safety sheet)

Diisopropyl_Cyanomethylphosphonate, MSDS

Diisopropyl Cyanomethylphosphonate, Synthesis Reference

No information avaliable

Diisopropyl Cyanomethylphosphonate, Molecular Weight

184.146 g/mol

Diisopropyl Cyanomethylphosphonate, Melting Point

-82 oC

Diisopropyl Cyanomethylphosphonate, H2O Solubility

1.54E+004 mg/L

Diisopropyl Cyanomethylphosphonate, State

Liquid

Diisopropyl Cyanomethylphosphonate, LogP

1.13

Diisopropyl Cyanomethylphosphonate, Dosage Forms

No information avaliable

Diisopropyl Cyanomethylphosphonate, Indication

For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.

Diisopropyl Cyanomethylphosphonate, Pharmacology

Isoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme.

Diisopropyl Cyanomethylphosphonate, Absorption

No information avaliable

Diisopropyl Cyanomethylphosphonate, side effects and Toxicity

Signs of overdose include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth.

Diisopropyl Cyanomethylphosphonate, Patient Information

No information avaliable

Diisopropyl Cyanomethylphosphonate, Organisms Affected

Humans and other mammals